Singular Health Group Limited (ASX:SHG) is an Australian medtech company focused on improving medical data interoperability. Its flagship software, 3DICOMTM, enables the seamless sharing of medical images across incompatible systems – reducing inefficiencies and unnecessary costs. The platform is FDA-cleared in the US and SHG recently secured its first major US commercial deal with Provider Network Solutions (PNS), a Managed Service Organisation (MSO) that works with health plans (health insurers), primary care providers and specialists. Unlike competitors that sell directly to hospitals or clinics, SHG’s go-to-market strategy is to partner with MSOs and health plans, as they are ultimately the payers in the system. A pilot with PNS runs through mid-2026, with success likely to lead to a rollout across PNS’s network covering 4.2m members. SHG also has a pipeline of other MSOs and health plans under consideration for future partnerships. Unnecessary duplicate medical imaging costs account for billions of dollars of waste in the US, making for a sizable market opportunity for SHG. The company appears well funded with $12.2m cash and at an inflection point with revenue likely to increase meaningfully over the next two years.
